Simon Waddington

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA.

Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California.

Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million.

Plastic Logic, Inc. develops plastic electronic technology solutions. is a private company that develops plastic electronic technology solutions. The comoany was founded by Stuart M. Evans, Richard Friend, Henning Sirringhaus in 2000 and it is headquartered in Mountain View, CA.

PolyTechnos Venture-Partners II GmbH (PTVP) is an independent partner-owned European private equity firm established in 1998 and based in Munich with a U.S. office in Silicon Valley. Their clients include financial institutions, banks, insurance companies, universities, foundations, corporations and fund-of-funds. They operate in close relationship with U.S. venture capital firms based on the West Coast. PTVP manages and divests a portfolio of private equity participations held through two maturing funds, namely the German fund PolyTechnos Venture Fund II and the UK fund Enabling Technology. PTVP's successor firm PT Capital-Partners GmbH was established in 2008.

Part of Evolva Holding SA, Abunda Nutrition, Inc. discovers, develops and commercializes next-generation food ingredients and product solutions. The company is based in San Francisco, CA. Abunda Nutrition was acquired by Evolva Holding SA on July 08, 2011 for $56.98 million.